[Federal Register Volume 86, Number 119 (Thursday, June 24, 2021)]
[Proposed Rules]
[Pages 33157-33159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13481]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

42 CFR Parts 412, 413, 425, 455, and 495

[CMS-1752-CN]
RIN 0938-AU44


Medicare Program; Hospital Inpatient Prospective Payment Systems 
for Acute Care Hospitals and the Long-Term Care Hospital Prospective 
Payment System and Proposed Policy Changes and Fiscal Year 2022 Rates; 
Quality Programs and Medicare Promoting Interoperability Program 
Requirements for Eligible Hospitals and Critical Access Hospitals; 
Proposed Changes to Medicaid Provider Enrollment; and Proposed Changes 
to the Medicare Shared Savings Program; Correction

AGENCY: Centers for Medicare & Medicaid Services (CMS), Department of 
Health and Human Services (HHS).

ACTION: Proposed rule; correction.

-----------------------------------------------------------------------

SUMMARY: This document corrects technical and typographical errors in 
the proposed rule that appeared in the May 10, 2021 Federal Register 
titled ``Medicare Program; Hospital Inpatient Prospective Payment 
Systems for Acute Care Hospitals and the Long Term Care Hospital 
Prospective Payment System and Proposed Policy Changes and Fiscal Year 
2022 Rates; Quality Programs and Medicare Promoting Interoperability 
Program Requirements for Eligible Hospitals and Critical Access 
Hospitals; Proposed Changes to Medicaid Provider Enrollment; and 
Proposed Changes to the Medicare Shared Savings Program.''

DATES: June 24, 2021.

FOR FURTHER INFORMATION CONTACT: 
    Katrina Hoadley, [email protected], Hospital Inpatient 
Quality Reporting Program.
    Julia Venanzi, [email protected], Hospital Inpatient 
Quality Reporting and Hospital Value-Based Purchasing Programs--
Administration Issues.

SUPPLEMENTARY INFORMATION:

I. Background

    In FR Doc. 2021-08888 of May 10, 2021 (86 FR 25070), there were a 
number of technical and typographical errors that are identified and 
corrected in this correcting document.

[[Page 33158]]

II. Summary of Errors

    On pages, 25473, 25475, 25484, and 25588 we made typographical and 
technical errors in footnotes and references to statutory citations and 
other sections of the proposed rule.
    On page 25471, in our discussion of the Hospital Value-based 
Purchasing (VBP) Program, we made errors in numbering the list of 
proposed Measure Suppression Factors.
    On pages 25489, 25491, and 25492, in our discussion of the Hospital 
VBP Program, we made errors in the achievement thresholds and 
benchmarks for the clinical outcomes domain performance standards that 
appear in the three tables.

III. Correction of Errors

    In FR Doc. 2021-08888 of May 10, 2021 (86 FR 25070), make the 
following corrections:

0
1. On page 25471, second column,
0
a. First partial paragraph, lines 6 and 7, the sentence ``The proposed 
Measure Suppression Factors are:'' is corrected to read ``The proposed 
measure suppression factors are as follows:''.
0
b. First through fifth full paragraphs, beginning with the phrase ``5. 
Significant deviation'' and ending with the phrase ``(iii) patient case 
volumes or facility-level case mix.'' are corrected to read as
    `` Significant deviation in national performance on the 
measure during the PHE for COVID-19, which could be significantly 
better or significantly worse compared to historical performance during 
the immediately preceding program years.
     Clinical proximity of the measure's focus to the relevant 
disease, pathogen, or health impacts of the PHE for COVID-19.
     Rapid or unprecedented changes in--
    ++ Clinical guidelines, care delivery or practice, treatments, 
drugs, or related protocols, or equipment or diagnostic tools or 
materials; or
    ++ The generally accepted scientific understanding of the nature or 
biological pathway of the disease or pathogen, particularly for a novel 
disease or pathogen of unknown origin.
     Significant national shortages or rapid or unprecedented 
changes in--
    ++ Healthcare personnel;
    ++ Medical supplies, equipment, or diagnostic tools or materials; 
or
    ++ Patient case volumes or facility-level case mix.''
0
2. On page 25473, third column, first full paragraph, line 2, the 
phrase ``section XX.H.1'', is corrected to read ``section V.H.1.''
0
3. On page 25475, third column, following the last paragraph, the 
column is corrected by adding footnote text (footnote 957) to read as 
follows:

    ``\957\ Zheng, Jun. SARS-CoV-2: an Emerging Coronavirus that 
Causes a Global Threat. Int J Biol Sci. 2020; 16(10): 1678-1685. 
Published online 2020 Mar 15. doi: 10.7150/ijbs.45053.''

0
4. On page 25484, lower two-thirds of the page, the table titled Table 
V.H.-6: Previously Adopted Baseline and Performance Periods for the FY 
2023 Program Year, the last table note, first line, the reference 
``section XX.X.3.c.'' is corrected to read ``section V.H.3.c.''.
0
5. On page 25489, middle of the page, the table titled ``Table V.H-11: 
Previously Established and Estimated Performance Standards for the FY 
2024 Program Year'', the entries for the clinical outcomes domain's 
achievement thresholds and benchmarks are corrected to read as follows:

Table V.H-11--Previously Established and Estimated Performance Standards
                      for the FY 2024 Program Year
------------------------------------------------------------------------
                                            Achievement
           Measure short name                threshold       Benchmark
------------------------------------------------------------------------
                        Clinical Outcomes Domain
------------------------------------------------------------------------
MORT-30-AMI ...........................        0.869247        0.887868
MORT-30-HF ............................        0.882308        0.907733
MORT-30-PN (updated cohort) ...........        0.840281        0.872976
MORT-30-COPD ..........................        0.916491        0.934002
MORT-30-CABG ..........................        0.969499        0.980319
COMP-HIP-KNEE * .......................        0.025396        0.018159
------------------------------------------------------------------------
 Per our proposal in section V.H.4.b. of the preamble of this
  proposed rule, the performance standards displayed in this table for
  the Safety domain measures were calculated using CY 2019 data.
* Lower values represent better performance.
 Previously established performance standards.

0
6. On page 25491, top half of the page, the table titled ``Table V.H-
13: Previously Established Performance Standards for the FY 2025 
Program Year'', the entries for the clinical outcomes domain's 
achievement thresholds and benchmarks are corrected to read as follows:

  Table V.H-13--Previously Established Performance Standards for the FY
                            2025 Program Year
------------------------------------------------------------------------
                                            Achievement
           Measure short name                threshold       Benchmark
------------------------------------------------------------------------
                        Clinical Outcomes Domain
------------------------------------------------------------------------
MORT-30-AMI.............................        0.872624        0.889994
MORT-30-HF..............................        0.883990        0.910344
MORT-30-PN (updated cohort).............        0.841475        0.874425
MORT-30-COPD............................        0.915127        0.932236
MORT-30-CABG............................        0.970100        0.979775
COMP-HIP-KNEE *.........................        0.025332        0.017946
------------------------------------------------------------------------
* Lower values represent better performance.


[[Page 33159]]

0
7. On page 25492, top half of the page, the table titled ``Table V.H-
14: Previously Established Performance Standards for the FY 2026 
Program Year'', the entries for the clinical outcomes domain's 
achievement thresholds and benchmarks are corrected to read as follows:

  Table V.H-14--Previously Established Performance Standards for the FY
                            2026 Program Year
------------------------------------------------------------------------
                                            Achievement
           Measure short name                threshold       Benchmark
------------------------------------------------------------------------
                        Clinical Outcomes Domain
------------------------------------------------------------------------
MORT-30-AMI.............................        0.874426        0.890687
MORT-30-HF..............................        0.885949        0.912874
MORT-30-PN (updated cohort).............        0.843369        0.877097
MORT-30-COPD............................        0.914691        0.932157
MORT-30-CABG............................        0.970568        0.980473
COMP-HIP-KNEE *.........................        0.024019        0.016873
------------------------------------------------------------------------
* Lower values represent better performance.

0
8. On page 25588, second column, footnote paragraph (footnote 1232), 
lines 3 through 5, the phrase ``2018: https://www.arthritis.org/Documents/Sections/About-Arthritis/arthritis-facts-stats-figures.pdf. 
Accessed March 8, 2019.'' is corrected to read ``2019: https://www.arthritis.org/getmedia/e1256607-fa87-4593-aa8a-8db4f291072a/2019-abtn-final-march-2019.pdf. Accessed May 13, 2021.''

Karuna Seshasai,
Executive Secretary to the Department, Department of Health and Human 
Services.
[FR Doc. 2021-13481 Filed 6-23-21; 8:45 am]
BILLING CODE 4120-01-P